Dr. Wanda Phipatanakul, MD, MS
Allergy & Immunology (Allergy & Immunology Physician)
At a glance
- Medical school
- Loma Linda University School of Medicine (1994)
- Years since graduation
- 32
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1994Medical school: Loma Linda University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Allergy & Immunology Physician primary
MA license 204416
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Children's Hospital Pediatric Associates, Inc (328 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 11 companies reported 104 payments worth $149,059 in total to this clinician.
| Genzyme Corporation | $56,306 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $37,073 |
| Genentech USA, Inc. | $19,018 |
| Ars Pharmaceuticals Operations, Inc. | $12,162 |
| Regeneron Pharmaceuticals, Inc. | $6,291 |
| Chiesi USA, Inc. | $6,206 |
| AstraZeneca Pharmaceuticals LP | $6,181 |
| Aero US Inc | $2,972 |
| Compensation for services other than consulting (speaking, faculty) | $101,233 |
|---|---|
| Travel and Lodging | $25,731 |
| Consulting Fee | $20,509 |
| Food and Beverage | $1,587 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $11,592 |
| Regeneron Healthcare Solutions, Inc. Apr 4, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $8,738 |
| Regeneron Healthcare Solutions, Inc. May 20, 2025 | Compensation for services other than consulting (speaking, faculty) | $8,738 |
| Genzyme Corporation Sep 24, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $8,388 |
| Genzyme Corporation Apr 8, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,340 |
| Chiesi USA, Inc. Dec 4, 2025 | Consulting Fee | $5,650 |
| Genentech USA, Inc. Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty) Xolair · Immunology | $5,000 |
| Genentech USA, Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) Xolair · Immunology | $5,000 |
| Regeneron Pharmaceuticals, Inc. Oct 10, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $4,893 |
| AstraZeneca Pharmaceuticals LP May 16, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,300 |
All 74 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $699 |
| Genentech USA, Inc. Dec 5, 2025 | Compensation for services other than consulting (speaking, faculty) Xolair · Immunology | $1,090 |
| Chiesi USA, Inc. Dec 4, 2025 | Consulting Fee | $5,650 |
| Chiesi USA, Inc. Dec 4, 2025 | Travel and Lodging travel to ORLANDO, FL | $525 |
| Eli Lilly and Company Nov 20, 2025 | Consulting FeeCompany’s descriptionSERVICES TO SUPPORT RESEARCH RELATED ACTIVITIES | $800 |
| Genentech USA, Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) Xolair · Immunology | $5,000 |
| Genentech USA, Inc. Oct 30, 2025 | Travel and Lodging Xolair · Immunology · travel to Houston, TX | $175 |
| Genentech USA, Inc. Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty) Xolair · Immunology | $5,000 |
| Aero US Inc Oct 18, 2025 | Consulting Fee AEROGEN SOLO NEBULIZER SYSTEM; AEROGEN USB CONTROLLER SYSTEM; AEROGEN SOLO NEBULIZER SYSTEM · RESPIRATORY | $2,972 |
| Regeneron Pharmaceuticals, Inc. Oct 10, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $4,893 |
| Regeneron Pharmaceuticals, Inc. Oct 10, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,398 |
| Genentech USA, Inc. Oct 8, 2025 | Travel and Lodging Xolair · Immunology · travel to Houston, TX · in-kind | $2,459 |
| Genentech USA, Inc. Oct 8, 2025 | Travel and Lodging Xolair · Immunology · travel to Houston, TX · in-kind | $396 |
| Genentech USA, Inc. Oct 8, 2025 | Travel and Lodging Xolair · Immunology · travel to Houston, TX · in-kind | $380 |
| Genentech USA, Inc. Oct 3, 2025 | Travel and Lodging Xolair · Immunology · travel to Oceanside, CA · in-kind | $2,372 |
| Genentech USA, Inc. Oct 3, 2025 | Travel and Lodging Xolair · Immunology · travel to Oceanside, CA · in-kind | $903 |
| Genentech USA, Inc. Oct 3, 2025 | Travel and Lodging Xolair · Immunology · travel to Oceanside, CA · in-kind | $797 |
| Genzyme Corporation Sep 24, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $8,388 |
| Genzyme Corporation Sep 24, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Charlotte, NC · in-kind | $1,404 |
| Genzyme Corporation Sep 24, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Charlotte, NC · in-kind | $1,129 |
| Regeneron Healthcare Solutions, Inc. Sep 23, 2025 | Travel and Lodging travel to SAN FRANCISCO, CA · in-kind | $885 |
| Circassia Inc. Sep 22, 2025 | Consulting Fee NIOX · Allergy and Asthma | $2,000 |
| Genentech USA, Inc. Sep 21, 2025 | Travel and Lodging Xolair · Immunology · travel to Houston, TX · in-kind | $15.00 |
| Genentech USA, Inc. Sep 4, 2025 | Travel and Lodging Xolair · Immunology · travel to Houston, TX · in-kind | $110 |
| Genzyme Corporation Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $2,097 |
| Genzyme Corporation Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $2,097 |
| Regeneron Healthcare Solutions, Inc. Aug 5, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to BOSTON, MA · in-kind | $233 |
| Regeneron Healthcare Solutions, Inc. Aug 5, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to BOSTON, MA · in-kind | $233 |
| Regeneron Healthcare Solutions, Inc. Aug 1, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to BOSTON, MA · in-kind | $278 |
| Genentech USA, Inc. Jul 25, 2025 | Travel and Lodging Xolair · Immunology · travel to Oceanside, CA · in-kind | $75.00 |
| Genentech USA, Inc. Jul 18, 2025 | Travel and Lodging Xolair · Immunology · travel to Oceanside, CA · in-kind | $55.00 |
| Genzyme Corporation Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $2,447 |
| Regeneron Healthcare Solutions, Inc. Jun 13, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,049 |
| Regeneron Healthcare Solutions, Inc. May 22, 2025 | Travel and Lodging travel to SAN FRANCISCO, CA · in-kind | $162 |
| Regeneron Healthcare Solutions, Inc. May 20, 2025 | Compensation for services other than consulting (speaking, faculty) | $8,738 |
| Regeneron Healthcare Solutions, Inc. May 20, 2025 | Travel and Lodging travel to SAN FRANCISCO, CA · in-kind | $377 |
| Regeneron Healthcare Solutions, Inc. May 17, 2025 | Travel and Lodging travel to SAN FRANCISCO, CA · in-kind | $162 |
| AstraZeneca Pharmaceuticals LP May 16, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,300 |
| Regeneron Healthcare Solutions, Inc. May 16, 2025 | Travel and Lodging travel to SAN FRANCISCO, CA · in-kind | $231 |
| AstraZeneca Pharmaceuticals LP May 6, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to New York, NY · in-kind Company’s descriptionSpeaker Expenses | $955 |
| AstraZeneca Pharmaceuticals LP May 6, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to New York, NY · in-kind Company’s descriptionSpeaker Expenses | $159 |
| Ars Pharmaceuticals Operations, Inc. Apr 23, 2025 | Travel and Lodging NEFFY · ALLERGY · travel to WALTHAM, MA | $16.17 |
| Ars Pharmaceuticals Operations, Inc. Apr 23, 2025 | Travel and Lodging NEFFY · ALLERGY · travel to NORTH ANDOVER, MA | $2.84 |
| Regeneron Healthcare Solutions, Inc. Apr 22, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,621 |
| Regeneron Healthcare Solutions, Inc. Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,759 |
| Genzyme Corporation Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $11,592 |
| Genzyme Corporation Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,845 |
| Ars Pharmaceuticals Operations, Inc. Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) NEFFY · ALLERGY | $3,250 |
| Ars Pharmaceuticals Operations, Inc. Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) NEFFY · ALLERGY | $3,250 |
| Genzyme Corporation Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,146 |
| Genzyme Corporation Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,146 |
| Genzyme Corporation Apr 9, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to New York, NY · in-kind | $278 |
| Genzyme Corporation Apr 8, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,340 |
| Genzyme Corporation Apr 8, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,845 |
| Genzyme Corporation Apr 8, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Brooklyn, NY · in-kind | $3,462 |
| Genzyme Corporation Apr 8, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Roslyn, NY · in-kind | $561 |
| Genzyme Corporation Apr 8, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Brooklyn, NY · in-kind | $273 |
| Regeneron Healthcare Solutions, Inc. Apr 4, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $8,738 |
| Regeneron Healthcare Solutions, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $3,146 |
| Regeneron Healthcare Solutions, Inc. Mar 27, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to ORLANDO, FL · in-kind | $230 |
| Regeneron Healthcare Solutions, Inc. Mar 26, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to ORLANDO, FL · in-kind | $359 |
| Regeneron Healthcare Solutions, Inc. Mar 26, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to WINTER PARK, FL · in-kind | $219 |
| Regeneron Healthcare Solutions, Inc. Mar 26, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to WINTER PARK, FL · in-kind | $193 |
| Regeneron Healthcare Solutions, Inc. Mar 25, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to WINTER PARK, FL · in-kind | $230 |
| Ars Pharmaceuticals Operations, Inc. Mar 19, 2025 | Travel and Lodging NEFFY · ALLERGY · travel to NORTH ANDOVER, MA · in-kind | $941 |
| Ars Pharmaceuticals Operations, Inc. Mar 19, 2025 | Travel and Lodging NEFFY · ALLERGY · travel to WALTHAM, MA · in-kind | $650 |
| Regeneron Healthcare Solutions, Inc. Mar 16, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to WINTER PARK, FL · in-kind | $468 |
| Regeneron Healthcare Solutions, Inc. Mar 16, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to WINTER PARK, FL · in-kind | $152 |
| Regeneron Healthcare Solutions, Inc. Mar 15, 2025 | Travel and Lodging travel to SAN FRANCISCO, CA · in-kind | $1,535 |
| Regeneron Healthcare Solutions, Inc. Mar 11, 2025 | Travel and Lodging travel to SAN FRANCISCO, CA · in-kind | $1,690 |
| Regeneron Healthcare Solutions, Inc. Mar 7, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $2,796 |
| AstraZeneca Pharmaceuticals LP Feb 18, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $450 |
| Ars Pharmaceuticals Operations, Inc. Jan 29, 2025 | Compensation for services other than consulting (speaking, faculty) NEFFY · ALLERGY | $3,900 |
| AstraZeneca Pharmaceuticals LP Jan 20, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $300 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $19,375 in research payments for these studies, mostly to the institutions running them.
- Effect of IL-4RaR576 polymorphism on response to Dupilumab in adolescents and adults with Asthma, a Genotype stratified, randomized-placebo controlled trial (I-DAG Study)
Regeneron Pharmaceuticals, Inc. - Study name not reported
GlaxoSmithKline, LLC. - PARK CABAL 1803 Allergen Specific Component Resolved Diagnostics and Atopic Progression Profiling in Context of Omalizumab Asthma Preventention Trial
Phadia US Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.